D.E. Shaw & Co
KRRO icon

D.E. Shaw & Co’s Korro Bio KRRO Stock Holding History

D.E. Shaw & Co’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,383
Closed -$305K – 4762
2025
Q2 		$305K Buy
+24,383
New +$351K ﹤0.01% 3865
2021
Q1 		– Sell
-368
Closed -$649K – 4281
2020
Q4 		$649K Buy
+368
New +$486K ﹤0.01% 3266
2020
Q1 		– Sell
-371
Closed -$325K – 4104
2019
Q4 		$325K Buy
+371
New +$289K ﹤0.01% 3597

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co's KRRO Position: Q3 2025 in Review

D.E. Shaw & Co sold out of Korro Bio (KRRO) in Q3 2025, closing a stake of 24,383 shares — an estimated $305K sold.

D.E. Shaw & Co first reported a position in KRRO in Q4 2019 and held it in 3 quarters. The position peaked at $649K in Q4 2020. 92 funds tracked by Wall St. Rank hold KRRO as of Q3 2025.

  • D.E. Shaw & Co reported no remaining Korro Bio position as of Q3 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 24,383 Korro Bio shares in Q3 2025, an estimated $305K.
  • D.E. Shaw & Co first reported a position in Korro Bio in Q4 2019 and held it in 3 quarters.
  • D.E. Shaw & Co's Korro Bio position peaked at $649K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Korro Bio as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.